cytomegalovirus vaccine (PREPS/L-particles vector) (Australian Centre for Vaccine Development/Henderson Morley)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namecytomegalovirus vaccine (PREPS/L-particles vector) (Australian Centre for Vaccine Development/Henderson Morley)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAustralian Centre for Vaccine Development
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAustralian Centre for Vaccine DevelopmentHenderson Morley plc
Active IndicationsN/A
Inactive IndicationsCytomegalovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A